Management Participants
- Mr. Deep Saraf – Managing Director
- Mr. Ashish Saraf – President - Strategic Planning and Business Development
- Mr. Ashok Jain – Director & Chief Financial Officer
- Ms. Ekta Soni – Associate Vice President, Investor Relations
- Mr. Deepak Sharma – Company Secretary & Compliance Officer
Moderator
Mr. Hiral Keniya – Ernst & Young LLP
Key Financial Performance (Consolidated)
Q2 FY27 Performance
- Revenue: INR459 crores, up 41.9% YoY from INR323 crores in Q2 FY26
- EBITDA: INR118 crores, up 34.4% YoY
- EBITDA Margin: 25.8% (impacted by higher inbound freight costs)
- Profit After Tax (PAT): INR81 crores, up 51.8% YoY
- PAT Margin: 17.6%, expanded by 114 basis points
H1 FY27 Performance
- Revenue: INR863 crores, up 40.8% YoY
- EBITDA: INR224 crores, up 38% YoY
- EBITDA Margin: 26%
- PAT: INR159 crores, up 59.2% YoY
- PAT Margin: 18.5%, expanded by 213 basis points
Revenue Mix
- Domestic: 39%
- Export: 61% (serving customers in 39+ countries across Asia, Europe, U.S., South America, Middle East, and Africa)
Balance Sheet & Cash Flow
- Inventory: INR1,000 crores as of September 30, 2026 (vs. INR728 crores in March 2026) due to early shea procurement alongside seasonal sal and mango seed procurement
- Operating Cash Flow: Outflow of INR252 crores for H1 (timing impact from inventory build-up)
- Net Debt-to-Equity: 0.04x (vs. 0.38x at FY26 end)
- Cash & Cash Equivalents: INR498 crores
- Working Capital: Funded through existing banking limits and internal resources
Other Income (H1)
- Forex Gain: INR15 crores
- Interest on FDR: INR10 crores
Business Highlights & Growth Drivers
- Volume vs. Realization Growth: 85% of revenue growth came from volumes, 10-15% from price realization
- Product Mix: Value-added products (CBE and stearin) now contribute ~75% of sales value (up from 65-70% previously)
- Plant Utilization: ~85% on expanded capacity of 47,500 tons
- Innovation: DSIR-certified Milcoa Innovation and Research Center developing application-specific products
Leadership Restructuring
Recent changes announced to create dedicated leadership for each business area:
- Mr. Mudit Kumar Singh: Chairman (focus on governance and risk oversight)
- Mr. Deep Saraf: Managing Director (operations, manufacturing, supply chain, project delivery)
- Mrs. Vinita Saraf: President, Business Excellence and Development (processes, operational capabilities, strategic growth)
- Mr. Ashish Saraf: President, Strategic Planning and Business Development (long-term strategy, global partnerships, new opportunities)
Growth Strategy (Four Pillars)
1. Expand capacity
2. Scale refining
3. Premiumize the mix
4. Expand globally
Expansion Projects & Capex Update
Current Capex Status
- Total investment to date: INR70-75 crores
- Expected additional investment in second half of FY27 and next fiscal year
- Capital work in progress: INR27 crores
Project Timelines
- Burkina Faso Backward Integration: Land acquired; regulatory approvals in progress; expected commissioning in Q3/Q4 FY28
- LATAM Facility: Gradual ramp-up expected over next year; currently shipping from Indian plants
- Debottlenecking (4,500 MTPA): Under planning for Q3 FY27
- Solvent Fractionation Plant: In planning and engineering stage
Expected Benefits
- Africa backward integration expected to provide 2-3% cost advantage at company level
- New capacities typically ramp up from 40-50% utilization initially to 85-90% over 2-3 years
- Asset turnover historically around 6x from forward integration investments
Operational Details
Capacity & Utilization
- Current capacity: 47,500 tons at ~85% utilization
- Debottlenecking expected to add 4,500 tons
- Target utilization: 85-90% for existing facilities
Raw Material Costs
- Raw material cost increased ~480 basis points YoY primarily due to higher freight costs
- Freight cost increase attributed to global macro events (Red Sea movements, fuel prices)
- Shea prices also impacted by 5-7% inflation
Demand Environment
- No slowdown observed despite geopolitical situation
- Capacities "quite booked" for the next year
- Healthy demand across product portfolio
Q&A Session Highlights
Inventory Management
- INR1,000 crore inventory includes shea nuts procured earlier from West African regions
- Inventory expected to normalize through second half
- Seasonal procurement pattern may vary year-to-year
Margin Outlook
- EBITDA margin band of 25-27% considered reasonable
- Modest quarter-to-quarter movements possible due to macroeconomic factors
- Expected improvement from operating leverage as new capacities ramp up
Growth Sustainability
- Company confident of maintaining growth trajectory
- Growth levers include: debottlenecking, value-added product mix improvement, price benefits
- Not providing specific numeric guidance
Receivables
- Increased 82% from March 2026 levels due to timing of September month revenue
- Normal payment terms of ~30 days
- Already receiving remittances from customers
Closing Remarks
Management expressed confidence in delivering the next phase of growth with discipline, citing integrated business model, strong sourcing capabilities, growing value-added portfolio, wider global reach, and robust balance sheet as key strengths positioning the company to capture long-term opportunities in CBE and specialty fats.